Nationwide Fund Advisors’s BioSpecifics Technologies Corp. BSTC Stock Holding History

Nationwide Fund Advisors’s Portfolio BSTC Stock Details BSTC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q4	–	Sell	-3,266	Closed	-$152K	–	2628
2017 Q3	$152K	Hold	3,266	–	–	﹤0.01%	2744
2017 Q2	$162K	Hold	3,266	–	–	﹤0.01%	2719
2017 Q1	$179K	Sell	3,266 -297	-8%	-$15.7K	﹤0.01%	2635
2016 Q4	$198K	Hold	3,563	–	–	﹤0.01%	2606
2016 Q3	$163K	Hold	3,563	–	–	﹤0.01%	2721
2016 Q2	$142K	Buy	3,563 +217	+6%	+$7.95K	﹤0.01%	2773
2016 Q1	$117K	Buy	3,346 +171	+5%	+$6.28K	﹤0.01%	2755
2015 Q4	$136K	Hold	3,175	–	–	﹤0.01%	2731
2015 Q3	$138K	Hold	3,175	–	–	﹤0.01%	2763
2015 Q2	$164K	Buy	3,175 +493	+18%	+$21K	﹤0.01%	2806
2015 Q1	$105K	Sell	2,682 -45	-2%	-$1.76K	﹤0.01%	2946
2014 Q4	$105K	Hold	2,727	–	–	﹤0.01%	2898
2014 Q3	$96K	Buy	2,727 +76	+3%	+$2.23K	﹤0.01%	2995
2014 Q2	$71K	Buy	+2,651	New	+$69.1K	﹤0.01%	3073
2013 Q3	–	Sell	-2,211	Closed	-$34K	–	3290
2013 Q2	$34K	Buy	+2,211	New	+$35.6K	﹤0.01%	3030

Other funds holding BSTC

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

SCM

Stonepine Capital Management Bend, Oregon $250M AUM 77.6% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

ECP

Elk Creek Partners Denver, Colorado $582M AUM 10.23% 1-Year Est. Return

RHJA

Rice Hall James & Associates San Diego, California $1.8B AUM 36.16% 1-Year Est. Return

AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return

EAM

Eagle Asset Management St Petersburg, Florida $19.6B AUM 41.58% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

Nationwide Fund Advisors's BSTC Position: Q4 2017 in Review

Nationwide Fund Advisors sold out of BioSpecifics Technologies Corp. (BSTC) in Q4 2017, closing a stake of 3,266 shares — an estimated $152K sold.

Nationwide Fund Advisors first reported a position in BSTC in Q2 2013 and held it in 15 quarters. The position peaked at $198K in Q4 2016. 88 funds tracked by Wall St. Rank hold BSTC as of Q4 2017.

Nationwide Fund Advisors reported no remaining BioSpecifics Technologies Corp. position as of Q4 2017 after selling out during the quarter.
Nationwide Fund Advisors sold 3,266 BioSpecifics Technologies Corp. shares in Q4 2017, an estimated $152K.
Nationwide Fund Advisors first reported a position in BioSpecifics Technologies Corp. in Q2 2013 and held it in 15 quarters.
Nationwide Fund Advisors's BioSpecifics Technologies Corp. position peaked at $198K in Q4 2016.
88 funds tracked by Wall St. Rank held BioSpecifics Technologies Corp. as of Q4 2017.

Based on Nationwide Fund Advisors's 13F filing for Q4 2017, filed 1 Feb 2018.